Utilizing both GPT-4 and computer vision technology, this AI tool identifies skin cancer in its early stages. Melanoma, the most fatal form of skin cancer, affects approximately 1 out of 5 Americans. By simply uploading or capturing an image of a mole, this tool can evaluate its nature, distinguishing between benign and malignant cases. Timely identification substantially enhances the likelihood of surviving skin cancer, with a staggering 99% success rate. Notably, the provided information does not pertain to any marketing or pricing details.